<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04022720</url>
  </required_header>
  <id_info>
    <org_study_id>IRB201901614</org_study_id>
    <nct_id>NCT04022720</nct_id>
  </id_info>
  <brief_title>Platelet-Rich Fibrin in Intraoral Soft Tissue Regeneration</brief_title>
  <official_title>Role of Platelet-Rich Fibrin in Intraoral Soft Tissue Regeneration of Head and Neck Surgery Patients: A Prospective Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Florida</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Florida</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Determine if the use of platelet rich fibrin (PRF) improves the rate and quality of healing&#xD;
      for intraoral mucosal and epithelial soft tissue defects.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    No patients enrolled. Also, impacted of COVID on enrolling subjects hindered recruitment.&#xD;
  </why_stopped>
  <start_date type="Actual">September 15, 2019</start_date>
  <completion_date type="Actual">August 3, 2020</completion_date>
  <primary_completion_date type="Actual">August 3, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in rate of healing in intraoral mucosa and epithelium soft tissues</measure>
    <time_frame>3 months post-operatively</time_frame>
    <description>Improved healing times of PRF patients compared to control group.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Mucosal Ulceration</condition>
  <arm_group>
    <arm_group_label>Platelet Rich Fibrin (PRF) Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients randomized to this group will receive treatment with a PRF graft.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No Platelet Rich Fibrin Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Participants in the observational control group will be managed at the time of the complication by standard of care methods.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Platelet Rich Fibrin Application</intervention_name>
    <description>Platelet Rich Fibrin application at first post-op visit.</description>
    <arm_group_label>Platelet Rich Fibrin (PRF) Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Three categories of patients will be included in this study:&#xD;
&#xD;
               1. Osteoradionecrosis (ORN) or medication related osteonecrosis of the jaw (MRONJ)&#xD;
                  patients who present to clinic with exposed bone and no clinical sign of&#xD;
                  infection.&#xD;
&#xD;
               2. Patients having an excisional biopsy in clinic performed under local anesthesia&#xD;
                  resulting in a defect that cannot be easily repaired without compromising normal&#xD;
                  anatomy or function. These situations include excisions which would result in&#xD;
                  primary closure under tension or with distorted anatomy, require a local flap, or&#xD;
                  require healing by secondary intention.&#xD;
&#xD;
               3. Patients presenting to the post-operative clinic with intraoral surgical wound&#xD;
                  dehiscence or an intraoral surgical wound healing by secondary intention.&#xD;
&#xD;
                  Exclusion Criteria:&#xD;
&#xD;
          -  Patients under 18 years of age.&#xD;
&#xD;
          -  Patient's unable to participate in blood draw either due to medical compromise,&#xD;
             inability to tolerate the procedure, or inability of the physician to successfully&#xD;
             draw the blood at the time of appointment.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Salam Salman, MD, DDS</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Florida</affiliation>
  </overall_official>
  <removed_countries>
    <country>United States</country>
  </removed_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>July 12, 2019</study_first_submitted>
  <study_first_submitted_qc>July 16, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 17, 2019</study_first_posted>
  <last_update_submitted>August 4, 2020</last_update_submitted>
  <last_update_submitted_qc>August 4, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 6, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>platelet rich fibrin (PRF)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ulcer</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>No IPD will be shared with other researchers</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

